STARGARDT
Clinical trials for STARGARDT explained in plain language.
Never miss a new study
Get alerted when new STARGARDT trials appear
Sign up with your email to follow new studies for STARGARDT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to halt vision loss in stargardt patients
Disease control Recruiting nowThis early-stage trial tests a gene therapy called ZVS106e for Stargardt disease, a genetic condition that causes vision loss. Nine participants will receive a single injection of the drug under their retina. The main goal is to check safety over 52 weeks, not yet to prove it wor…
Matched conditions: STARGARDT
Phase: EARLY_PHASE1 • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study aims to map how stargardt disease worsens over time
Knowledge-focused Recruiting nowThis observational study will follow 75 people aged 12 to 65 with Stargardt disease type 1, a genetic eye condition that causes vision loss. Researchers will use eye exams and imaging to track how the disease changes over time. The goal is to better understand the disease's progr…
Matched conditions: STARGARDT
Sponsor: Splice Bio • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:54 UTC